Stay updated on DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Sign up to get notified when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.

Latest updates to the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA sitewide NIH notice about agency terminology changes and related updates was removed. The clinical-trial page itself continues to display a 403 Forbidden error.SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA banner announces NIH’s transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) and links to updates and FAQs.SummaryDifference1%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer revision advanced from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check37 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page now displays a 403 Forbidden error page with the site header and footer shown, indicating restricted access to the content.SummaryDifference18%

Stay in the know with updates to DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Enter your email address, and we'll notify you when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.